PepGen Shareholders’ Equity Growth & History (PEPG)
PepGen's shareholders’ equity was $147.4M for fiscal 2025.
View full PepGen company overviewPepGen annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $147.4M | $28.8M | +24.30% |
| 2024 | 2024-12-31 | $118.6M | $10.2M | +9.41% |
| 2023 | 2023-12-31 | $108.4M | −$71.2M | −39.64% |
| 2022 | 2022-12-31 | $179.6M | $211.7M | — |
| 2021 | 2021-12-31 | −$32.1M | — | — |
PepGen quarterly shareholders’ equity
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $119.5M | $48.4M | +67.98% |
| Q1 2026 | 2026-03-31 | $134.0M | $42.2M | +45.94% |
| Q4 2025 | 2025-12-31 | $147.4M | $28.8M | +24.30% |
| Q3 2025 | 2025-09-30 | $163.1M | $25.7M | +18.69% |
| Q2 2025 | 2025-06-30 | $71.2M | −$83.9M | −54.10% |
| Q1 2025 | 2025-03-31 | $91.8M | −$87.2M | −48.71% |
| Q4 2024 | 2024-12-31 | $118.6M | $10.2M | +9.41% |
| Q3 2024 | 2024-09-30 | $137.5M | $11.6M | +9.21% |
| Q2 2024 | 2024-06-30 | $155.0M | $7.8M | +5.27% |
| Q1 2024 | 2024-03-31 | $179.0M | $14.2M | +8.59% |
| Q4 2023 | 2023-12-31 | $108.4M | −$71.2M | −39.64% |
| Q3 2023 | 2023-09-30 | $125.9M | −$67.1M | −34.77% |
| Q2 2023 | 2023-06-30 | $147.3M | −$62.9M | −29.94% |
| Q1 2023 | 2023-03-31 | $164.8M | $214.4M | — |
| Q4 2022 | 2022-12-31 | $179.6M | $211.7M | — |
| Q3 2022 | 2022-09-30 | $192.9M | — | — |
| Q2 2022 | 2022-06-30 | $210.2M | — | — |
| Q1 2022 | 2022-03-31 | −$49.6M | — | — |
| Q4 2021 | 2021-12-31 | −$32.1M | — | — |
PepGen shareholders’ equity trends
Between the periods ended 2021-12-31 and 2025-12-31, PepGen's shareholders’ equity increased from −$32.1M to $147.4M, a change of $179.5M. The latest reported quarter, Q2 2026, shows $119.5M.
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PepGen source filings ↗Community posts
Novartis’ DM1 trial misses its primary endpoint
Novartis’ ($NVS) del-desiran failed to show a statistically significant improvement on the primary endpoint in the Phase III HARBOR trial for myotonic dystrophy type 1. The company will continue analysing the data and discuss next steps wit ...